Arch Therapeutics, Inc. (ARTH)

Arch Therapeutics Revenue

Arch Therapeutics had revenue of $31.87K in the quarter ending March 31, 2024, with 91.34% growth. This brings the company's revenue in the last twelve months to $130.54K, up 324.67% year-over-year. In the fiscal year ending September 30, 2023, Arch Therapeutics had annual revenue of $75.72K with 383.80% growth.

• Revenue (ttm): $130.54K
• Revenue Growth: +324.67%
• P/S Ratio: 3.83
• Revenue / Employee: $16,318
• Employees: 8
• Market Cap: 500.01K

Revenue History

Fiscal Year End	Revenue	Change	Growth
Sep 30, 2023	75.72K	60.07K	383.80%
Sep 30, 2022	15.65K	4.09K	35.34%
Sep 30, 2021	11.57K	-	-
Sep 30, 2020	-	-	-
Sep 30, 2019	-	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.